Overview


According to FutureWise analysis, the market for Bovine Plasma is expected to grow with a CAGR of 5.8% over the forecast period 2024-2032, and reach a market value of US$ 1.34 Billion by 2031. 

Bovine plasma is the liquid component of blood obtained from cattle, specifically cows. It is a rich source of various proteins, including albumin, globulins, fibrinogen, and clotting factors, crucial for various physiological functions. Bovine plasma is obtained through a process known as blood fractionation, where whole blood is centrifuged to separate the cellular components (such as red blood cells and white blood cells) from the liquid plasma. This plasma contains many bioactive compounds, including enzymes, hormones, antibodies, and other signalling molecules. These bioactive components are essential in immune function, coagulation, and transporting nutrients and waste products throughout the body.

Bovine plasma is used in various applications across industries. Agriculture commonly uses it as a source of essential nutrients for livestock, providing proteins and other vital factors necessary for growth and development. Additionally, bovine plasma has applications in the food industry, where it is used as an ingredient in various products, particularly in formulating nutritional supplements for humans and animals. In biotechnology and medical research, bovine plasma is a valuable protein source for cell culture media and various research applications. It provides essential nutrients and growth factors for cultivating cells in a laboratory setting.

FutureWise Market Research has published a report that provides an insightful analysis of Bovine Plasma Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts' projects that the Bovine Plasma Market will experience a significant growth. According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.

  • Thermo Fisher Scientific
  • Moregate BioTech
  • Gemini
  • Cambridge Bioscience Limited.
  • Bio-Techne
  • VWR International, LLC.
  • Otto Chemie Pvt. Ltd.
  • BioVision Inc 
  • Pel-Freez, LLC
  • Canvax Reagents S.L.
  • GeneTex, Inc
  • Cygnus Technologies
  • Equitech-Bio
  • 3H Biomedical AB
  • Atlanta Biologicals
  • Tissue Culture Biologicals
  • Bovogen Biologicals Pty Ltd

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent developments by key players in Bovine Plasma Market:

  • A study published in the National Library of Medicine on December 27, 2021, revealed noteworthy enhancements in the properties of films produced from bovine plasma following a process involving acidification and the reinforcement of nanofibrillated cellulose (NFC). Compared to untreated plasma control films, those incorporating ethanol-extracted proteins exhibited superior mechanical strength and water vapor barrier characteristics. Films containing 10% NFC significantly improved these attributes and reduced water solubility while maintaining their optical qualities, such as light transmittance and transparency index. Furthermore, the research uncovered that it is facile to integrate antibacterial agents like nisin into the formulation of these films.

Bovine plasma is a rich source of essential nutrients and bioactive compounds, making it a valuable ingredient in animal feed formulations. The increasing emphasis on animal health and nutrition drives the demand for bovine plasma in the livestock industry. Bovine plasma is used to produce biologics, including vaccines and therapeutic proteins. The biopharmaceutical industry's expansion is fueling the demand for high-quality bovine plasma as a critical raw material. Bovine plasma is vital in cell culture media for cultivating various cell types in research and biomanufacturing settings. The growing field of cell-based therapies and biotechnology research contributes to the demand for bovine plasma. The emphasis on animal welfare and health, driven by consumer preferences and regulatory standards, promotes using high-quality and safe bovine plasma products in animal nutrition and fuels market growth.

However, ensuring bovine plasma products' safety and quality is paramount, especially with concerns about potential contaminants, such as pathogens. Meeting and adhering to regulatory standards can take time and effort for manufacturers. Proper screening and testing protocols are crucial to mitigate the risk of transmitting diseases through bovine plasma products. This concern necessitates rigorous quality control measures in collecting and processing bovine plasma, hindering market growth.

By Grade

  • Technical
  • Standard

By Origin

  • U.S.
  • Australia
  • New Zealand
  • Others (Brazil, Mexico, etc.)

By Application

  • Cell Culture Media
  • Vaccine Production
  • Drug Discovery
  • Others (Forensic Studies, in vitro diagnostics, etc.)

By End User

  • Biopharmaceutical Industry
  • Academic & Research Institutes
  • Others (Diagnostic Laboratories, Forensic Laboratories, etc.)

By Region

  • Europe
  • North America
  • Asia Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of the region will also be provided in the final version of this market, which is based on the conclusion of primary interviews and secondary data points gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered the highest share in the market in 2022 due to rising demand in animal nutrition, growing application in biopharmaceuticals, robust healthcare infrastructure, the prominent presence of key industry players, a surge in chronic disease cases, and heightened research endeavors in this geographical region. 

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Bovine Plasma Market By Grade, By Origin, By Application, By End User, and By Region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape, mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.  Market Introduction

    •   1. Objectives of the Study 
        2. Market Definition 
        3. Market Scope 
           3.1. Years Considered for the Study
           3.2. Market Covered
        4. Currency 
        5. Limitations 
        6. Stakeholders 

  • 2.  Research Methodology

    •   1 Research Data 
           1.1. Secondary Data
              1.1.1. Key Data from Secondary Sources
           1.2 Primary Data
              1.2.1. Key Data from Primary Sources
        3.Market Size Estimation 
        4. Market Breakdown and Data Triangulation 
        5. Assumptions for the Study 

  • 3.  Executive Summary

    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights

  • 4.  Bovine Plasma Market Variables, Trends & Scope

    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Application Overview
        6. Regulatory Framework
           6.1. Reimbursement Framework
           6.2. Standards and Compliances

  • 5.  Market Overview

    •   1. Market Dynamics
           1.1. Market Driver Analysis
              1.1.1. Increasing focus of Bovine Plasma Market Companies on Brand Protection
              1.1.2. Untapped Opportunities in Emerging Regions
           1.2. Market Restraint Analysis
              1.2.1. High Cost Associated with Implementation of Predictive Analysis
           1.3. Industry Challenges
              1.3.1. Presence of Ambiguous Regulatory Framework

  • 6.  Bovine Plasma Market Analysis Tools

    •   1. Industry Analysis - Porter’s
           1.1. Supplier Power
           1.2. Buyer Power
           1.3. Substitution Threat
           1.4. Threat from New Entrants
           1.5. Competitive Rivalry
        2. Pestel Analysis
           2.1. Political Landscape
           2.2. Environmental Landscape
           2.3. Social Landscape
           2.4. Application Landscape
           2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
           3.1. Joint Ventures
           3.2. Mergers and Acquisitions
           3.3. Licensing and Partnership
           3.4. Application Collaborations
           3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies

  • 7.  Bovine Plasma Market, By Grade Historical Analysis and Forecast 2024-2032 (USD Million)
      1. Technical
      2. Standard
         
  • 8.  Bovine Plasma Market, By Origin Historical Analysis and Forecast 2024-2032 (USD Million)
      1.  U.S.
      2. Australia
      3. New Zealand
      4. Others (Brazil, Mexico, etc.)
         
  • 9.  Bovine Plasma Market, By Application Historical Analysis and Forecast 2024-2032 (USD Million)
      1. Cell Culture Media
      2. Vaccine Production
      3. Drug Discovery
      4. Others (Forensic Studies, in vitro diagnostics, etc.)
         
  • 10.  Bovine Plasma Market, By End User Historical Analysis and Forecast 2024-2032 (USD Million)
      1. Biopharmaceutical Industry
      2. Academic & Research Institutes
      3. Others (Diagnostic Laboratories, Forensic Laboratories, etc.)
         
  • 11.  North America Bovine Plasma Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. U.S.A
           2.2. Canada
           2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2024-2032

  • 12.  Latin America Bovine Plasma Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. Brazil
           2.2. Venezuela
           2.3. Argentina
           2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2024-2032

  • 13.  Europe Bovine Plasma Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. Germany
           2.2. U.K
           2.3. France
           2.4. Italy
           2.5. Spain
           2.6. Russia
           2.7. Poland
           2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2024-2032

  • 14.  Asia Pacific Bovine Plasma Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. Japan
           2.2. China
           2.3. India
           2.4. Australia and New Zealand
           2.5. ASEAN
           2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2024-2032

  • 15.  Middle East and Africa Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. GCC
           2.2. Israel
           2.3. South Africa
           2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2024-2032

  • 16.  Market Share Analysis and Competitive Landscape

    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix

  • 17.  Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts)

    •   1. Thermo Fisher Scientific
           1.1. Company Overview
           1.2. Product Portfolio
           1.3. SWOT Analysis
           1.4. Financial Overview
           1.5. Strategic Overview
        2. Moregate BioTech
           2.1. Company Overview
           2.2. Product Portfolio
           2.3. SWOT Analysis
           2.4. Financial Overview
           2.5. Strategic Overview
        3. Gemini
           3.1. Company Overview
           3.2. Product Portfolio
           3.3. SWOT Analysis
           3.4. Financial Overview
           3.5. Strategic Overview
        4. Cambridge Bioscience Limited
           4.1. Company Overview
           4.2. Product Portfolio
           4.3. SWOT Analysis
           4.4. Financial Overview
           4.5. Strategic Overview
        5.  Bio-Techne
           5.1. Company Overview
           5.2. Product Portfolio
           5.3. SWOT Analysis
           5.4. Financial Overview
           5.5. Strategic Overview
        6. VWR International, LLC
           6.1. Company Overview
           6.2. Product Portfolio
           6.3. SWOT Analysis
           6.4. Financial Overview
           6.5. Strategic Overview
        7. Otto Chemie Pvt. Ltd.
           7.1. Company Overview
           7.2. Product Portfolio
           7.3. SWOT Analysis
           7.4. Financial Overview
           7.5. Strategic Overview
        8. BioVision Inc
           8.1. Company Overview
           8.2. Product Portfolio
           8.3. SWOT Analysis
           8.4. Financial Overview
           8.5. Strategic Overview
        9. Pel-Freez, LLC
           9.1. Company Overview
           9.2. Product Portfolio
           9.3. SWOT Analysis
           9.4. Financial Overview
           9.5. Strategic Overview
        10. Canvax Reagents S.L.
           10.1. Company Overview
           10.2. Product Portfolio
           10.3. SWOT Analysis
           10.4. Financial Overview
           10.5. Strategic Overview
        11. GeneTex, Inc
           11.1. Company Overview
           11.2. Product Portfolio
           11.3. SWOT Analysis
           11.4. Financial Overview
           11.5. Strategic Overview
        12. Cygnus Technologies
           12.1. Company Overview
           12.2. Product Portfolio
           12.3. SWOT Analysis
           12.4. Financial Overview
           12.5. Strategic Overview
        13. Equitech-Bio
           13.1. Company Overview
           13.2. Product Portfolio
           13.3. SWOT Analysis
           13.4. Financial Overview
           13.5. Strategic Overview
        14. 3H Biomedical AB
           14.1. Company Overview
           14.2. Product Portfolio
           14.3. SWOT Analysis
           14.4. Financial Overview
           14.5. Strategic Overview
        15. Atlanta Biologicals
           15.1. Company Overview
           15.2. Product Portfolio
           15.3. SWOT Analysis
           15.4. Financial Overview
           15.5. Strategic Overview
        16. Tissue Culture Biologicals
           16.1. Company Overview
           16.2. Product Portfolio
           16.3. SWOT Analysis
           16.4. Financial Overview
           16.5. Strategic Overview
        17. Bovogen Biologicals Pty Ltd
           17.1. Company Overview
           17.2. Product Portfolio
           17.3. SWOT Analysis
           17.4. Financial Overview
           17.5. Strategic Overview

  • 18.   Pre and Post COVID-19 Impact

    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by
            administrations
        5. The overall economic slowdown of the developing and developed nations

  • 19.  FutureWise SME Key Takeaway Points for Client

    •   


Ask for Discount
Buy Now
Customize This Report
  • We Offer Special Discounts for start-ups, NGOs, and Educational & Research institutions.

Need Assistance

  • UK : +44 141 628 9353
  • US : +1 347 709 4931

What you get

  • Excel Dataset
  • Market Overview
  • Infographics
  • PowerPoint Presentation
  • PDF Report

What's included

  • Consumer Perception and Procurement
  • Market Data Forecast
  • Competitive Analysis
  • Risks and Opportunity Assessment
  • Market Trends and Dynamics
Partner

Our Clients

image0
image1
image2
image3
image4
image5
image6
image7
image8
image9
image10
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11